Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP465139.RAW8VDhjyWhVqO7TdJfgun5oBxPKg29T9R0qD2JNOPp_A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP465139.RAW8VDhjyWhVqO7TdJfgun5oBxPKg29T9R0qD2JNOPp_A130_assertion type Assertion NP465139.RAW8VDhjyWhVqO7TdJfgun5oBxPKg29T9R0qD2JNOPp_A130_head.
- NP465139.RAW8VDhjyWhVqO7TdJfgun5oBxPKg29T9R0qD2JNOPp_A130_assertion description "[The aim of the present study was 1) to examine the mRNA and protein expression of PPARgamma in gastric cancer (GC); 2) to evaluate the effect of PPARgamma ligand (ciglitazone) on the proliferation and apoptosis of GC cell line; and 3) to assess the levels of gastric tissue proinflammatory cytokines, IL-1beta and IL-8, and plasma gastrin in GC patients before and after Helicobacter pylori (H. pylori) eradication.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP465139.RAW8VDhjyWhVqO7TdJfgun5oBxPKg29T9R0qD2JNOPp_A130_provenance.
- NP465139.RAW8VDhjyWhVqO7TdJfgun5oBxPKg29T9R0qD2JNOPp_A130_assertion evidence source_evidence_literature NP465139.RAW8VDhjyWhVqO7TdJfgun5oBxPKg29T9R0qD2JNOPp_A130_provenance.
- NP465139.RAW8VDhjyWhVqO7TdJfgun5oBxPKg29T9R0qD2JNOPp_A130_assertion SIO_000772 15492468 NP465139.RAW8VDhjyWhVqO7TdJfgun5oBxPKg29T9R0qD2JNOPp_A130_provenance.
- NP465139.RAW8VDhjyWhVqO7TdJfgun5oBxPKg29T9R0qD2JNOPp_A130_assertion wasDerivedFrom befree-2016 NP465139.RAW8VDhjyWhVqO7TdJfgun5oBxPKg29T9R0qD2JNOPp_A130_provenance.
- NP465139.RAW8VDhjyWhVqO7TdJfgun5oBxPKg29T9R0qD2JNOPp_A130_assertion wasGeneratedBy ECO_0000203 NP465139.RAW8VDhjyWhVqO7TdJfgun5oBxPKg29T9R0qD2JNOPp_A130_provenance.